100 related articles for article (PubMed ID: 8141625)
1. [Transitional carcinoma of the prostate. Report of a case treated with chemotherapy].
Parra Muntaner L; Verdú Martínez M; Kilani Elmasri S; Monsalve Rodríguez M; Gómez Cisneros S; Martín Castillo J; García Alonso J
Arch Esp Urol; 1993 Dec; 46(10):909-12. PubMed ID: 8141625
[TBL] [Abstract][Full Text] [Related]
2. [A case of primary transitional cell carcinoma of the prostate].
Konya E; Nose K; Kiwamoto H; Kataoka K; Kajikawa H; Kurita T
Hinyokika Kiyo; 1999 Jun; 45(6):439-42. PubMed ID: 10442290
[TBL] [Abstract][Full Text] [Related]
3. [A case of primary transitional cell carcinoma of the prostate responsive to combination chemotherapy with methotrexate, epirubicin and cisplatin].
Abe K; Ohishi Y; Onodera S; Kiyota H; Asano K
Hinyokika Kiyo; 1998 Jun; 44(6):415-7. PubMed ID: 9719942
[TBL] [Abstract][Full Text] [Related]
4. [A case of primary transitional cell carcinoma of the prostate].
Hashimoto H; Watanabe Y; Mizunaga M; Sasaki M; Kaneko S; Tokunaka S; Yachiku S; Fujita M
Hinyokika Kiyo; 1989 Jul; 35(7):1235-8. PubMed ID: 2678986
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
6. [Primary transitional cell carcinoma of prostate: a case report].
Uemura M; Imamura R; Inoue H; Nishimura K; Mizutani S; Miyoshi S; Mise T
Hinyokika Kiyo; 2000 Jul; 46(7):495-8. PubMed ID: 10965459
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
8. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium.
Dreicer R; Manola J; Roth BJ; See WA; Kuross S; Edelman MJ; Hudes GR; Wilding G
Cancer; 2004 Apr; 100(8):1639-45. PubMed ID: 15073851
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
Urushibara M; Tsukamoto T; Horiuchi S; Negishi T
Hinyokika Kiyo; 1998 Jul; 44(7):501-3. PubMed ID: 9752607
[TBL] [Abstract][Full Text] [Related]
10. [Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy].
Prié L; Gaston R; Ferrière JM; Richaud P; Bui BN; Guillou ML
Cancer Radiother; 1998 Apr; 2 Suppl 1():62s-66s. PubMed ID: 9749081
[TBL] [Abstract][Full Text] [Related]
11. Carcinomatous meningitis from transitional cell carcinoma of the urinary bladder.
Kastritis E; Zagouri F; Dimopoulos MA; Papadimitriou CA
J BUON; 2011; 16(2):373-4. PubMed ID: 21766515
[No Abstract] [Full Text] [Related]
12. [A case of primary urothelial carcinoma of the prostate responsive to MVAC intra-arterial chemotherapy: a case report].
Maruyama T; Yamada Y; Ueda Y; Higuchi Y; Nojima M; Yamamoto S; Zouzumi M; Hirota S; Hashimoto T; Doi Y; Yabumoto H; Yoshida T
Hinyokika Kiyo; 2011 May; 57(5):255-9. PubMed ID: 21743284
[TBL] [Abstract][Full Text] [Related]
13. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
[TBL] [Abstract][Full Text] [Related]
14. [Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].
Takahashi Y; Yamamoto N; Deguchi T; Kuriyama M; Yoh M; Yasuda M; Nakano M; Kawada Y; Takeuchi T; Shinoda I
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1310-3. PubMed ID: 9703815
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
[TBL] [Abstract][Full Text] [Related]
16. [A case report of a young patient with invasive bladder cancer].
Nakashima M; Nishiyama H; Yagihashi Y; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
Hinyokika Kiyo; 2003 Dec; 49(12):745-8. PubMed ID: 14978958
[TBL] [Abstract][Full Text] [Related]
17. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
18. [Triple malignancy including bladder carcinoma, prostate carcinoma and malignant lymphoma: a case report].
Kobayashi Y; Yasunaga Y; Yoshioka T; Matsuda M; Oritani K; Kuyama J; Ohnishi S; Tada Y; Miyagawa M
Hinyokika Kiyo; 1989 Nov; 35(11):1925-8. PubMed ID: 2618890
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
Abi-Aad AS
Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
[No Abstract] [Full Text] [Related]
20. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
Hatano K; Kawashima A; Arai Y; Inoue H; Miyagawa Y; Takaha N; Nishimura K; Miyake O; Okuyama A
Hinyokika Kiyo; 2006 Oct; 52(10):801-3. PubMed ID: 17131872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
